Tumor Lysis Syndrome Initiative

LIVE interactive webinar — earn pharmacy CPE credit!

Prevention and Treatment of an Oncologic Emergency: Focus on Tumor Lysis Syndrome

Activity Content

As a valued member of the health care team that manages the care of oncology patients, pharmacists are in a key position to impact the care of patients at risk for developing or those that present with oncologic emergencies, including tumor lysis syndrome (TLS). TLS, a group of metabolic abnormalities resulting from the spontaneous or treatment-related rapid break down of malignant tumor cells, is a serious and potentially life-threatening medical emergency. When TLS occurs, it is essential that the patient receive prompt medical attention in order to prevent the acute complications that can have severe repercussions, including death of the patient.

This program will help pharmacists appropriately identify patients who are at high risk of developing TLS.  Monitoring and providing treatment options for patients who develop this medical emergency or those for whom prophylactic therapy is warranted will also be addressed.  Case studies will be used to illustrate key concepts.

Learning Objectives

After participating in this application-based educational activity, participants should be able to

• Summarize current clinical data regarding the safety and efficacy of agents used for the management of tumor lysis syndrome (TLS).
• Presented with a clinical case, design a treatment plan for a patient with TLS and a patient determined to be at high risk for development of TLS.
• Make therapeutics recommendations for prophylaxis and treatment of TLS in patients at risk for its development that include an assessment of the cost effectiveness of various therapeutic alternatives.

Faculty

Kamakshi V. Rao, Pharm.D., BCOP
Oncology Clinical Pharmacy Specialist
University of North Carolina Hospitals and Clinics
Chapel Hill, North Carolina

Methods and Format

This is a live online activity consisting of audio, online presentation slides, and an activity evaluation tool. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. Participants may print their official statements of continuing pharmacy education credit immediately. This activity is provided free of charge.

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 1.0 hour (0.1 CEU) of continuing pharmacy education credit (ACPE Activity #204-000-08-440-L01P).

Target Audience

This continuing education program was planned to meet the needs of pharmacists who practice in oncology or are interested in improving the identification and management of tumor lysis syndrome (TLS).

Disclosure Statements

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of program content disclose their relevant financial relationships.  A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the CME activity content over which the individual has control.  The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.

All faculty and planners for ASHP Advantage education activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests.  ASHP Advantage identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.

The faculty and planners report the following relationships:

• Kamakshi V. Rao, Pharm.D., BCOP declares that she has no relationships pertinent to this activity.
• Erika L. Thomas, M.B.A, R.Ph. declares that she has no relationships pertinent to this activity

Webinar Frequently Asked Questions

 

What is a live webinar?

A live webinar brings the presentation to you — at your desk, in your home, through a staff in-service. You listen to the speaker presentation in “real time” as you watch the slides on the screen. You will have the opportunity to ask the speaker questions at the end of the program.

How do I process my CPE?

A CPE activity code and session code will be provided during this presentation. At any time following this presentation, each individual participant will be able to complete a Continuing Pharmacy Education Request online and print their CPE statement of credit at the ASHP Learning Center at http://ce.ashp.org.

»Click here for full CPE processing instructions for webinars

What do I need in order to participate in the webinar?

1. Telephone to dial the toll-free number and listen to the presentation.
2. Computer with internet access and basic system requirements. When you register, the webinar system will assess your system to ensure compatibility.

What if I would like to arrange for my colleagues to participate in this webinar as a group?

One person should register for the webinar. That person will then be e-mailed computer linking and telephone dial-in instructions. After the webinar, each participant will process his/her CPE statement online.

Tuesday, October 6, 2009
12 noon – 1 pm Eastern
» Register Now

 

Planned and conducted by ASHP Advantage. Supported by an educational grant from sanofi-aventis

Contact ASHP Advantage for assistance or questions • System Requirements
Copyright 2008 • Trademark • ASHP Privacy Policy